跳至主要内容
临床试验/ITMCTR2100005365
ITMCTR2100005365尚未招募未知

To explore the mechanism of NF-?B signaling pathway on diabetic peripheral neuropathy by using the method of

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Age 18-75;
  • 2. Inpatients meeting the diagnostic criteria for diabetes;
  • 3. Meet the diagnostic criteria for DPN in the 2017 Chinese Guidelines for the Prevention and Treatment of Type 2 diabetes;
  • 4. Blood glucose control was stable for more than 2 weeks under hypoglycemic drugs and insulin treatment: FPG=8mmol/L, 2hPG=11mmol/L, and HbA1c= 8%;
  • 5. Self-care, normal thinking, capable of language communication;
  • 6. Those who voluntarily participate in the study and sign the informed consent;
  • 7. Patients who had been in the Department of Endocrinology of The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine for =4 weeks.

排除标准

  • 1. Patients with damaged skin integrity at acupoint selection and pestle site, dermatitis, allergy and other skin diseases, or skin allergy to metal;
  • 2. Ketosis and ketoacidosis;
  • 3. Acute infectious diseases;
  • 4. Varicose veins or edema of lower limbs;
  • 5. After lower limb vascular surgery;
  • 6. Complicated with serious primary diseases of heart, liver, kidney and hematopoietic system and mental diseases;
  • 7. Severe visual impairment or blindness;
  • 8. Cancer patients;
  • 9. Pregnant patients.

研究者

发起方
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

相似试验